title: Is it time for medicine-based evidence?
authors.forename: John
authors.initials: J
authors.lastname: Concato
mesh_terms: D017732:Air Ambulances / Q000706:statistics & numerical data*; D000552:Ambulances / Q000706:statistics & numerical data*; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017544:Aortic Aneurysm, Abdominal / Q000401:mortality* / Q000601:surgery*; D000068258:Bevacizumab; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004632:Emergency Medical Services / Q000379:methods*; D057510:Endovascular Procedures / Q000401:mortality*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000401:mortality* / Q000601:surgery*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D006278:Medicare / Q000706:statistics & numerical data*; D009392:Nephrectomy / Q000379:methods* / Q000401:mortality*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects*; D014656:Vascular Surgical Procedures / Q000401:mortality*; D014947:Wounds and Injuries / Q000401:mortality*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab